1. Home
  2. SPRB vs TIRX Comparison

SPRB vs TIRX Comparison

Compare SPRB & TIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • TIRX
  • Stock Information
  • Founded
  • SPRB 2014
  • TIRX 2010
  • Country
  • SPRB United States
  • TIRX China
  • Employees
  • SPRB N/A
  • TIRX N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • TIRX Specialty Insurers
  • Sector
  • SPRB Health Care
  • TIRX Finance
  • Exchange
  • SPRB Nasdaq
  • TIRX Nasdaq
  • Market Cap
  • SPRB 15.7M
  • TIRX 16.7M
  • IPO Year
  • SPRB 2020
  • TIRX 2021
  • Fundamental
  • Price
  • SPRB $0.33
  • TIRX $1.57
  • Analyst Decision
  • SPRB Hold
  • TIRX
  • Analyst Count
  • SPRB 7
  • TIRX 0
  • Target Price
  • SPRB $2.17
  • TIRX N/A
  • AVG Volume (30 Days)
  • SPRB 300.3K
  • TIRX 13.1K
  • Earning Date
  • SPRB 03-21-2025
  • TIRX 08-16-2024
  • Dividend Yield
  • SPRB N/A
  • TIRX N/A
  • EPS Growth
  • SPRB N/A
  • TIRX N/A
  • EPS
  • SPRB N/A
  • TIRX N/A
  • Revenue
  • SPRB $7,101,000.00
  • TIRX $3,219,336.00
  • Revenue This Year
  • SPRB N/A
  • TIRX N/A
  • Revenue Next Year
  • SPRB N/A
  • TIRX N/A
  • P/E Ratio
  • SPRB N/A
  • TIRX N/A
  • Revenue Growth
  • SPRB N/A
  • TIRX 158.74
  • 52 Week Low
  • SPRB $0.33
  • TIRX $1.38
  • 52 Week High
  • SPRB $1.29
  • TIRX $7.40
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 27.09
  • TIRX 46.86
  • Support Level
  • SPRB $0.34
  • TIRX $1.47
  • Resistance Level
  • SPRB $0.36
  • TIRX $1.58
  • Average True Range (ATR)
  • SPRB 0.03
  • TIRX 0.09
  • MACD
  • SPRB -0.01
  • TIRX 0.00
  • Stochastic Oscillator
  • SPRB 2.70
  • TIRX 60.00

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

Share on Social Networks: